STOCK TITAN

Arvinas (NASDAQ: ARVN) files to sell 5,134 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arvinas, Inc. had an affiliated holder file a Form 144 notice to sell 5,134 shares of its common stock through Morgan Stanley Smith Barney LLC on or about 02/13/2026 on the NASDAQ market. The shares have an aggregate market value of $61,052.92 based on the figures provided.

The securities to be sold arose from the settlement of vested restricted stock units acquired from Arvinas on 02/13/2026, with payment noted as not applicable. Common shares outstanding were 64,224,294 at the time referenced, providing context for the relative size of this planned sale.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 for a modest Rule 144 stock sale from vested RSUs.

A holder associated with Arvinas, Inc. filed a Form 144 to sell 5,134 common shares, with an aggregate market value of $61,052.92. The planned sale will be executed through Morgan Stanley Smith Barney LLC on NASDAQ under Rule 144.

The filing shows the shares come from settlement of vested restricted stock units on 02/13/2026, with no special financing or installment structure. With 64,224,294 common shares outstanding, this proposed sale appears small in scale and looks like routine liquidity from equity compensation rather than a thesis-changing event.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Arvinas (ARVN) Form 144 filing disclose?

The Form 144 shows a holder plans to sell 5,134 Arvinas common shares. The shares, valued at about $61,052.92, will be sold on NASDAQ through Morgan Stanley Smith Barney LLC under Rule 144, following settlement of vested restricted stock units.

How many Arvinas (ARVN) shares are planned for sale under this Form 144?

The filing covers a proposed sale of 5,134 common shares of Arvinas, Inc. These shares come from settlement of vested restricted stock units and have an indicated aggregate market value of approximately $61,052.92 based on the figures in the notice.

When are the Arvinas (ARVN) shares in the Form 144 expected to be sold?

The Form 144 lists an approximate sale date of 02/13/2026 for the 5,134 Arvinas common shares. That date also matches the acquisition date from settlement of vested restricted stock units disclosed in the same filing section.

What is the source of the Arvinas (ARVN) shares being sold in this Form 144?

The Form 144 states the 5,134 Arvinas common shares come from a settlement of vested restricted stock units. The acquisition date is shown as 02/13/2026, and the nature of payment is marked not applicable, consistent with equity compensation settlement.

Which broker will handle the Arvinas (ARVN) Form 144 share sale?

The filing identifies Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York, NY, as the broker. This firm is listed as handling the potential sale of 5,134 Arvinas common shares on the NASDAQ exchange.

How does the planned Arvinas (ARVN) Form 144 sale compare with shares outstanding?

The Form 144 notes 64,224,294 Arvinas common shares outstanding. The planned Rule 144 sale of 5,134 shares is small relative to this base, indicating a modest transaction compared with the company’s total outstanding shares.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

748.21M
59.11M
6.85%
94.18%
11.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN